Holen Sie sich die Stockscreener-App
0.7485
8.16%
-0.0665
Vorhandelsmarkt:
.75
0.0015
+0.20%
Schlusskurs vom Vortag:
$0.815
Offen:
$0.81
24-Stunden-Volumen:
145.77K
Relative Volume:
0.62
Marktkapitalisierung:
$8.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-10.47%
1M Leistung:
-21.14%
6M Leistung:
+14.36%
1J Leistung:
-98.45%
1-Tages-Spanne:
$0.74
$0.81
1-Wochen-Bereich:
$0.74
$0.874
52-Wochen-Spanne:
$0.375
$64.80
AEON Biopharma Inc. Stock (AEON) Company Profile
Firmenname
AEON Biopharma Inc.
Sektor
Branche
Telefon
(949) 354-6499
Adresse
5 Park Plaza, Suite 1750, Irvine
Vergleichen Sie AEON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.7485 | 9.65M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-18 | Eingeleitet | H.C. Wainwright | Buy |
AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten
How AEON Biopharma Inc. Class stock performs in volatility spikesQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
Can AEON Biopharma Inc. Class stock retain market dominanceJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
AEON Biopharma Releases New Corporate Presentation - TipRanks
AEON Biopharma : Corporate Presentation - marketscreener.com
AEON Biopharma (NYSE: AEON) releases new investor Corporate Presentation - Stock Titan
AEON Biopharma, Inc. Releases Corporate Presentation on Biosimilar Development - TradingView
Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight - GlobeNewswire Inc.
Aeon Biopharma Reports Positive Data and Strategic Moves - MSN
Aeon Secures Funding As FDA Sets New Date For Botox Biosimilar Review - Citeline News & Insights
Check out these key findings about AEON Biopharma Inc (AEON) - Setenews
How AEON Biopharma Inc. Class stock valuation compares with sector2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
AEON Biopharma (NASDAQ:AEON) Upgraded at Zacks Research - Defense World
Aeon Biopharma announces first closing of PIPE investment and provides update on FDA Type 2A meeting scheduling - MarketScreener
Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling - TradingView
AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling - The Manila Times
AEON Biopharma Inc: FDA Bpd Type 2a Meeting N - 富途牛牛
Can AEON Biopharma Inc. Class stock survive global slowdownWeekly Profit Analysis & Expert Curated Trade Setup Alerts - newser.com
Will AEON Biopharma Inc. Class stock beat international competitionWeekly Earnings Recap & Capital Protection Trading Alerts - newser.com
Applying big data sentiment scoring on AEON Biopharma Inc.July 2025 PostEarnings & Verified Short-Term Plans - newser.com
Why AEON Biopharma Inc. Class stock signals breakout potentialPortfolio Gains Summary & Smart Allocation Stock Reports - newser.com
Will AEON Biopharma Inc. Class stock announce special dividendBreakout Watch & Verified High Yield Trade Plans - newser.com
Will AEON Biopharma Inc. Class stock return to pre crash levelsTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com
What earnings margins imply for AEON Biopharma Inc. Class stockMarket Performance Summary & AI Enhanced Trade Execution Alerts - newser.com
Is AEON Biopharma Inc. Class stock among top earnings plays2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
How forex fluctuations impact AEON Biopharma Inc. Class stockJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com
Will AEON Biopharma Inc. price bounce be sustainableJuly 2025 Technicals & Expert Curated Trade Setup Alerts - newser.com
Can AEON Biopharma Inc. stock resist market sell offs - newser.com
Published on: 2025-11-19 04:38:24 - newser.com
How big funds are accumulating AEON Biopharma Inc. Class stock2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Relative strength of AEON Biopharma Inc. in sector analysisTrade Entry Report & Consistent Profit Alerts - newser.com
Is AEON Biopharma Inc. stock attractive for ETFsQuarterly Profit Summary & Verified Entry Point Signals - newser.com
Finanzdaten der AEON Biopharma Inc.-Aktie (AEON)
Es liegen keine Finanzdaten für AEON Biopharma Inc. (AEON) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
Kapitalisierung:
|
Volumen (24h):